MIAMI, Feb 19, 2018—Leslie Mesen, M.D., a leader in the field of anti-aging medicine in Latin America and medical director of Global Stem Cells Group affiliate Stem Cell Center in Escazu, Costa Rica, will be a keynote speaker at the International Association for Stem Cell Application (ISSCA) Regenerative Medicine Cell Therapies Symposium in Istanbul, Turkey April 28, 2018.
Leslie Mesen, M.D.
Three months post-injury, the patient’s foot wound was not healing. Mesen administered an SVF autologous stem cell procedure and, four-weeks post-stem cell treatment, the wound showed significant improvement (70 percent wound closure) with clear new tissue growth visible around the wound. Mesen then performed an activated PRP procedure to further stimulate cell division.
Two weeks after the PRP treatment, the patient was walking in shoes, and underwent a final stem cell procedure. Over a period of five weeks, the patient—an electrician– recovered the ability to care for himself. He is expected to return to work soon.
Mesen is board certified in anti-aging and regenerative medicine by The American Academy of Anti-Aging Medicine and a pioneer in anti-aging medicine in Latin America.
He has extensive experience as the chief medical officer of three highly recognized anti-aging institutes: Costagenics Age Management program (2007-2010), Anti-Aging Institute of the Americas (2010-2013) and the Anti-Aging and Wellness Clinic (2014- present).
Mesen studied medicine at Universidad Iberoamericana (UNIBE) in San José, Costa Rica and receives continuing education courses in the United States and Latin America. In the U.S., he has trained at the University of Miami Jackson Memorial Hospital. His range of services encompass all aspects of aging, delivering programs tailored to each patient’s unique needs. Mesen offers platelet-rich plasma (PRP) therapy, HRT, hair regrowth treatments, intravenous infusions, and a range of other anti-aging and aesthetic treatments.
The Istanbul international symposium is part of ISSCA’s mission to support a paradigm shift from traditional healthcare solutions to regenerative medicine and provide the latest innovative discoveries and developments in all areas of stem cell research. The symposium will host a group of renowned international speakers, experts in the field of stem cell and regenerative medicine, who will provide a full day of rigorous scientific discourse directed to physicians.
The day’s events will incorporate information on stem cell biology, medicine, applications, regulations, product development, and commercialization, business opportunities, challenges, and potential strategies for overcoming those challenges.
To participate in the ISSCA Istanbul Symposium, reserve your spot by registering today.
For more information, visit the stemcellconference.org website, email info@stemcellsgroup.com, or call +1305 560 5337.
About International Society for Stem Cell Application (ISSCA):
The International Society for Stem Cell Application (ISSCA) is a multidisciplinary community of scientists and physicians, all of whom aspire to treat diseases and lessen human suffering through advances in science, technology and the practice of regenerative medicine. ISSCA serves its members through advancements made to the specialty of regenerative medicine.
The ISSCA’s vision is to take a leadership position in promoting excellence and setting standards in the regenerative medicine fields of publication, research, education, training, and certification.
As a medical specialty, regenerative medicine standards and certifications are essential, which is why ISSCA offers certification training in cities all over the world. The goal is to encourage more physicians to practice regenerative medicine
and make it available to benefit patients both nationally and globally. Incorporated under the Republic of Korea as a non-profit entity, the ISSCA is focused on promoting excellence and standards in the field of regenerative medicine.
###
ISSCA Leslie Mesen
- Published in Press Releases
ISSCA Announces Regenerative Medicine Cell Therapies Symposium in Istanbul, Turkey April 28, 2018
(Image: Istanbul, Turkey)
The International Association for Stem Cell Application (ISSCA) has announced plans to host a regenerative medicine symposium in Istanbul, Turkey April 28, 2018.
MIAMI, Feb 14, 2018—The International Association for Stem Cell Application (ISSCA) has announced plans to host a regenerative medicine symposium in Istanbul, Turkey April 28, 2018. The symposium will focus on new advances in cell therapies.
The Istanbul international symposium is part of ISSCA’s mission to support a shift from traditional healthcare solutions to regenerative medicine and provide the latest innovative discoveries and developments in all areas of stem cell research. The symposium will host a group of renowned international speakers, experts in the field of stem cell and regenerative medicine, who will provide a full day of rigorous scientific discourse directed to physicians.
The day’s events will incorporate information on stem cell biology, medicine, applications, regulations, product development, and commercialization, business opportunities, challenges, and potential strategies for overcoming those challenges.
To learn more about the ISSCA symposium in Istanbul and to register to attend, visit the stemcellconference.org website, email info@stemcellsgroup.com, or call +1305 560 5337.
About International Society for Stem Cells Applications
The International Society for Stem Cell Application (ISSCA) is a multidisciplinary community of scientists and physicians, all of whom aspire to treat diseases and lessen human suffering through advances in science, technology and the practice of regenerative medicine. ISSCA serves its members through advancements made to the specialty of regenerative medicine.
The ISSCA’s vision is to take a leadership position in promoting excellence and setting standards in the regenerative medicine fields of publication, research, education, training, and certification.
As a medical specialty, regenerative medicine standards and certifications are essential, which is why ISSCA offers certification training in cities all over the world. The goal is to encourage more physicians to practice regenerative medicine and make it available to benefit patients both nationally and globally. Incorporated under the Republic of Korea as a non-profit entity, the ISSCA is focused on promoting excellence and standards in the field of regenerative medicine.
Regenerative Medicine symposium Istanbul
- Published in Press Releases
Global Stem Cells Group to Launch Regenerative Medicine Training Program for Mexico at Congreso Internacional de Medicina Antienvejecimiento y Longevidad
(Image: Regenerative Medicine Training Program for Mexico)
MIAMI, Feb. 14, 2018— Global Stem Cells Group, a world leader in stem cell and regenerative medicine, will launch the organization’s complete Regenerative Medicine Training Program for Mexico at the IX Congreso Internacional de Medicina Antienvejecimiento y Longevidad (Congress in Anti-Aging and Longevity Medicine) to be held February 16 – 18, 2018 in Mexico City.
The training course will be held in Mexico City April 13 – 14, 2018.
The “Practical Course of Cell Therapies in a Clinical Environment” is a two-day, hands-on training course that provides physician attendees with the intellectual property of 22 proprietary protocols that allow treatment procedures for degenerative and aesthetic conditions and diseases in-office, as well as step-by-step videos of each protocol.
Course attendees will acquire the skills that will allow them to offer alternative therapies to patients who suffer from degenerative conditions for which no traditional medical solutions are available. Attendees will treat three to five live patients during the course. Upon completing the course successfully, participants will join a select group of physicians at the forefront of medical science—only 5 percent of physicians worldwide have access to studies of cell therapies, and only 0.01 percent are currently practicing these therapies.
Qualified physicians learn skills that can be used to treat patients in-practice, and utilize the training for career advancement.
Participating physicians will also receive access to the online stem cell training course to review all content and procedures introduced in the 2-day clinical training course, patient forms and guidelines, procedure informed consent forms, didactic lectures, training booklets, and more.
The Regenerative Medicine Training Program for Mexico was developed for physicians and high-level practitioners to learn techniques in harvesting and reintegrating stem cells. Stem cell therapies continue to revolutionize the healthcare industry and help improve the quality of life for patients.
To learn more about the certification training course and register to participate, visit the Stem Cell Training Course website, email info@stemcellsgroup.com, or call 305-560-5337.
About Global Stem Cells Group
Global Stem Cells Group (GSCG) is a worldwide network that combines seven major medical corporations, each focused on furthering scientific and technological advancements to lead cutting-edge stem cell development, treatments, and training. The united efforts of GSCG’s affiliate companies provide medical practitioners with a one-stop hub for stem cell solutions that adhere to the highest medical standards.
Global stem cell’s mission is to be the largest recognized stem cell and regenerative medicine network in the world.
Regenerative Medicine Training for Mexico
- Published in Press Releases
Global Stem Cells Group CEO Benito Novas to be a Keynote Speaker at Congreso Internacional de Medicina Antienvejecimiento y Longevidad Feb. 16-18, 2018
Benito Novas, Global Stem Cells Group CEO
MIAMI, Feb. 14, 2018— Global Stem Cells Group founder and CEO Benito Novas will be a keynote speaker at the IX Congreso Internacional de Medicina Antienvejecimiento y Longevidad (Congress in Anti-Aging and Longevity Medicine) February 16 – 18, 2018 in Mexico City. The conference is organized by The Institute of Anti-Aging and Longevity Medicine, the leading anti-aging and regenerative medicine society in Mexico.
Novas, a global entrepreneur and medical marketing professional in the fields of biotechnology, life sciences, and healthcare development, will share his expertise on the latest marketing tools for managing a medical practice. Topics will include social media strategies and tools for promoting physician practices, and how to design Google and Facebook ads that generate targeted leads and engage new potential patients.
The healthcare industry is continuously pursuing new and improved medical and technological advancements, treatments, and expanded healthcare opportunities that offer a higher level of patient care. The industry serves a uniquely broad audience, and today’s consumers are searching online for medical providers.
In fact, the majority of consumers rely on the internet to find healthcare providers.
For this reason, Novas says it is critical for medical practices and providers to stay on top of digital marketing strategies and trends in order to keep their organizations competitive and to generate new leads in today’s patient-centric market.
Novas will join healthcare professionals from around the world who specialize in treatments for conditions and diseases affecting aging and elderly patients from around the world for the anti-aging conference in Mexico City later this month.
Instituto de Medicina Antenvejecimiento Longevidad
The conference will be held at Hotel Reforma in Mexico City.
To learn more or register for the IX Congreso Internacional de Medicina Antienvejecimiento y Longevidad, visit the conference website. For information on Benito Novas and regenerative and stem cell medicine, visit the Global Stem Cells Group website, email info@stemcellsgroup.com, or call +1 305 560 5337.
About Global Stem Cells Group
Global Stem Cells Group (GSCG) is a worldwide network that combines seven major medical corporations, each focused on furthering scientific and technological advancements to lead cutting-edge stem cell development, treatments, and training. The united efforts of GSCG’s affiliate companies provide medical practitioners with a one-stop hub for stem cell solutions that adhere to the highest medical standards.
Global stem cell’s mission is to be the largest recognized stem cell and regenerative medicine network in the world.
Benito Novas keynote speaker
- Published in Press Releases
Global Stem Cells Group to Sponsor Congreso Internacional de Medicina Antienvejecimiento y Longevidad Feb. 16-18, 2018
(Image: Hotel Reforma, Mexico City)
MIAMI, Feb. 14, 2018— Global Stem Cells Group, a world leader in stem cell and regenerative medicine, will sponsor the IX Congreso Internacional de Medicina Antienvejecimiento y Longevidad (Congress in Anti-Aging and Longevity Medicine) to be held February 16 – 18, 2018 in Mexico City. This will be the third consecutive year GSCG is sponsoring the Congress.
Global Stem Cells Group founder and CEO Benito Novas will join healthcare professionals from around the world for the event. Anti-aging medicine focuses on early detection, prevention, treatment, and regeneration for conditions related to advanced age and promotes. innovative therapy and protocol development for the therapeutic management of aging and elderly patients. Four-hundred participants are expected to attend.
Instituto de Medicina Antenvejecimiento Longevidad
A lineup of world-renowned physicians, all leaders in anti-aging medicine, will teach magisterial conferences throughout the event. There will also be practical theoretic workshops related to anti-aging, regenerative, and aesthetic medicine. Additionally, conference attendees will be able to witness various procedures performed by expert anti-aging practitioners.
The conference is organized by The Institute of Anti-Aging and Longevity Medicine, the leading anti-aging and regenerative medicine society in Mexico.
IX Congress attendees will be granted recognition for their participation and will have access to the event’s commercial area where they can purchase products and learn about business opportunities with leading national and international companies specializing in anti-aging medicine.
The conference will be held at Hotel Reforma in Mexico City.
To learn more or register for the IX Congreso Internacional de Medicina Antienvejecimiento y Longevidad, visit the conference website. For information on regenerative and stem cell medicine, visit the Global Stem Cells Group website, email info@stemcellsgroup.com, or call +1 305 560 5337.
About Global Stem Cells Group
Global Stem Cells Group (GSCG) is a worldwide network that combines seven major medical corporations, each focused on furthering scientific and technological advancements to lead cutting-edge stem cell development, treatments, and training. The united efforts of GSCG’s affiliate companies provide medical practitioners with a one-stop hub for stem cell solutions that adhere to the highest medical standards.Global stem cell’s mission is to be the largest recognized stem cell and regenerative medicine network in the world.
Congress in Anti-Aging and Longevity Medicine
- Published in Press Releases
Global Stem Cells Group names Mehmet Veli Karaaltın, M.D. to Advisory Board
(Image: Mehmet Veli Karaaltın, M.D.)
MIAMI, Jan. 18, 2018—Global Stem Cells Group CEO Benito Novas has named Mehmet Veli Karaaltın, M.D., Associate Professor of Plastic, Aesthetic, and Reconstructive Surgery, (European Board Certified), and hand surgery, head, and maxillofacial surgery specialist to the GSCG Advisory Board Faculty.
Karaaltın practices in Istanbul, Turkey.
Born in Iraq-Kirkuk in 1972, Karaaltın moved to the United States with his family, living in West Lafayette, Indiana and Los Angeles until 1988, when he moved to Istanbul.
After graduating from Istanbul University’s Cerrahpaşa English Medical Faculty, Karaaltın received a national examination from Hacettepe University in Ankara, Turkey, where he was 12th out of 25000 doctoral candidates. In 2012, he passed and completed all ID exams required by the European Society of Plastic Surgery. He is a member of the European Council of Plastic Reconstructive and Aesthetic Surgery and the International Society of Aesthetic Plastic Surgery (ISAPS).
In addition to his work in aesthetic applications, Karaaltın is also known for his work in microvascular free flaps, nerve transfers, facial surgery, and tissue transplants.
Karaaltın also practices cellular therapy and tissue regeneration for healing diabetic wounds, severe burns, and Buerger’s disease. He is one of only a few physicians in the world who offer surgical treatment for Lymphedema-Elephant Disease with microvascular lymph node transfer. In addition, Karaaltın uses
3-D technology to perform aesthetic rhinoplasty.
“It is a pleasure to welcome Dr. Karaaltın to the Global Stem Cells Group Advisory Board,” says GSCG CEO Benito Novas. “He brings a wealth of knowledge in aesthetic regenerative medicine to the table, and we look forward to a long and productive alliance.”
To learn more, visit the Global Stem Cells Group website, email inf@stemcellsgroup.com, or call +1 305 560 5337.
About Global Stem Cells Group:
Global Stem Cells Group (GSCG) is a worldwide network that combines seven major medical corporations, each focused on furthering scientific and technological advancements to lead cutting-edge stem cell development, treatments, and training. The united efforts of GSCG’s affiliate companies provide medical practitioners with a one-stop hub for stem cell solutions that adhere to the highest medical standards.
Global stem cell’s mission is to be the largest recognized stem cell and regenerative medicine network in the world.
Mehmet Veli Karaaltın, M.D.
- Published in Press Releases
ISSCA President Daeyong Kim, Ph.D. Announces Next Chapter Meeting to be Held Jan. 24 – 26, 2018 in Seoul, Korea
ISSCA President Daeyong Kim, Ph.D., and Vice President Benito Novas to hold next ISSCA chapter meeting in Seoul, Korea Jan. 24-26, 2018.
MIAMI, Jan. 18, 2018— ISSCA President Daeyong Kim, Ph.D. has announced the next chapter meeting will be held Jan. 24 – 26, 2018 in Seoul, Korea.
The meeting will be held by Kim and ISSCA Vice President Benito Novas and will address all ISSCA chapter directors and board members.
ISSCA Chapter directors from the U.S., Costa Rica, Argentina, Spain, and Morocco will be in attendance. During the three-day event, chapter directors will receive training in the latest regenerative medicine clinical application protocols as well as applications for manipulating and harvesting stem cells in lab conditions.
ISSCA will also establish strategies for 2018, focusing on promoting excellence and setting standards in the field of publication, research, related education, and certification in regenerative medicine during the event.
The organization intends to set the entire 2018 agenda for regenerative medicine training for 2018 during the meeting, including:
• The Hands on Training Agenda
• The Cell Therapy and Engineering Tissue Fellowship
To learn more about ISSCA, visit the stemcellglobal.org website, email info@stemcellsgroup.com, or call +1305 560 5337.
About ISSCA:
The International Society for Stem Cell Application (ISSCA) is a multidisciplinary community of scientists and physicians, all of whom aspire to treat diseases and lessen human suffering through advances in science, technology and the practice of regenerative medicine. ISSCA serves its members through advancements made to the specialty of regenerative medicine.
The ISSCA’s vision is to take a leadership position in promoting excellence and setting standards in the regenerative medicine fields of publication, research, education, training, and certification.
As a medical specialty, regenerative medicine standards and certifications are essential, which is why ISSCA offers certification training in cities all over the world. The goal is to encourage more physicians to practice regenerative medicine and make it available to benefit patients both nationally and globally. Incorporated under the Republic of Korea as a non-profit entity, the ISSCA is focused on promoting excellence and standards in the field of regenerative medicine.
ISSCA chapter meeting
- Published in Press Releases
ISSCA President Daeyong Kim, Ph.D. Names Junaid Sayed, M.D. President of ISSCA’s U.S. Chapter
(Image: Junaid A. Syed, M.D.)
ISSCA President Daeyong Kim, Ph.D., has named Junaid Sayed, M.D. president of ISSCA’s U.S. chapter.
MIAMI, Jan. 18, 2018—International Society for Stem Cell Application (ISSCA) President Daeyong Kim, Ph.D., has named Junaid Sayed, M.D. president of ISSCA’s U.S. chapter. Sayed is Board Certified physician with extensive training in aesthetic medicine.
As president of the U.S. chapter, Sayed will represent and promote ISSCA activities the USA, including ISSCA’s Stem Cell Certification Training and Stem Cell Conference events. He will also share the latest information on regenerative medicine clinical applications with the U.S, medical community.
“We are happy to have Dr. Sayed represent ISSCA in the U.S., and as a collaborator in our efforts to introduce new clinical applications to the medical community,” says Kim. “He brings a wealth of experience and expertise to the ISSCA organization.”
To learn more about ISSCA, visit the stemcellglobal.org website, email info@stemcellsgroup.com, or call +1305 560 5337.
About ISSCA:
The International Society for Stem Cell Application (ISSCA) is a multidisciplinary community of scientists and physicians, all of whom aspire to treat diseases and lessen human suffering through advances in science, technology and the practice of regenerative medicine. ISSCA serves its members through advancements made to the specialty of regenerative medicine.
The ISSCA’s vision is to take a leadership position in promoting excellence and setting standards in the regenerative medicine fields of publication, research, education, training, and certification.
As a medical specialty, regenerative medicine standards and certifications are essential, which is why ISSCA offers certification training in cities all over the world. The goal is to encourage more physicians to practice regenerative medicine and make it available to benefit patients both nationally and globally. Incorporated under the Republic of Korea as a non-profit entity, the ISSCA is focused on promoting excellence and standards in the field of regenerative medicine.
- Published in Press Releases
Global Stem Cells Group Subsidiary Stem Cell Center Network to open new facility in Puerto Rico
MIAMI, Jan. 15, 2018—Global Stem Cells Group (GSCG) subsidiary Stem Cell Center Network, the world’s largest collective support and advisory network of regenerative medicine clinics and physicians, has announced the opening a new facility in San Jose, Puerto Rico in January 2018.
Stem Cell Center Puerto Rico will provide stem cell treatments for a variety of conditions, including osteoarthritis, erectile dysfunction, and urinary incontinence. Adimarket, also a subsidiary of GSCG, will provide Stem Cell Center Puerto Rico with state-of-the-art products and technology, such as the Integrated Stem Cell Workstation.
Global Stem Cells Group CEO Benito Novas named Juan Colon, M.D. to head Stem Cell Center Puerto Rico as medical director. Colon is a urologist who has spent the past year working to help prostate cancer patients. He earned his medical degree from Recinto de Ciencias Médicas in San Juan and trained in the latest regenerative medicine protocols in December 2017 at Stem Cell Center San Jose, Costa Rica.
The Stem Cell Center Network has aggressively launched and rapidly expanded new fellowship programs, events, and other regenerative medicine events over the past five years and currently has members practicing in 25 countries.
The new San Juan center will treat patients with a variety of degenerative conditions with emphasis on osteoarthritis, according to Novas.
For more information, visit the Stem Cell Center Network website, the Global Stem Cells Group website, email info@stemcellsgroup.com, or call +1305 560 5337.
About Global Stem Cells Group:
Global Stem Cells Group (GSCG) is a worldwide network that combines seven major medical corporations, each focused on furthering scientific and technological advancements to lead cutting-edge stem cell development, treatments, and training. The united efforts of GSCG’s affiliate companies provide medical practitioners with a one-stop hub for stem cell solutions that adhere to the highest medical standards.
Global stem cell’s mission is to be the largest recognized stem cell and regenerative medicine network in the world.
About Stem Cell Center Network:
Stem Cell Center Network, a division of Global Stem Cells Group, is an international network of medical practitioners dedicated to bringing stem cell therapies to patients worldwide.
Network physicians are experts in their fields and believe that stem cell treatments are to the future of medicine. Each Network physician is dedicated to providing the best treatments and contributing to the global store of regenerative medicine knowledge and research.
About Adimarket:
Adimarket, Inc., a division of the Global Stem Cells Group, is a one-stop, cost-competitive online marketplace for quality regenerative medicine equipment and supplies for physicians and healthcare professionals.
Adimarket was founded to provide practitioners the tools they need to practice regenerative medicine in a medical office setting. Motivated by a firm belief in the impact stem cell medicine can have when dispensed in a doctor’s office, Adimarket provides physicians with the tools they need to provide patients with cutting-edge treatments.
- Published in Press Releases
ISSCA to Conduct Regenerative Medicine Training in Mexico City Feb.9-10, 2018
ISSCA will conduct the next regenerative medicine certification training course in Mexico City, Feb. 9-10, 2018. The two-day course focuses on harvesting adipose and bone marrow stem cells from patients in a clinical environment.
MIAMI, Jan. 15, 2018—The International Society for Stem Cell Application (ISSCA) announced plans to hold its next regenerative medicine certification training course in Mexico City, Feb. 9 – 10, 2018.
The two-day, hands-on training course will focus on harvesting adipose and bone marrow stem cells from patients in a clinical environment. Qualified physicians learn skills that can be used to treat patients in their practices, and for career advancement. The course provides participating physicians with training in stem cell applications to treat a variety of conditions.
Participating physicians will also receive access to the online stem cell training course to review all content and procedures introduced in the 2-day clinical training course, patient forms and guidelines, procedure informed consent forms, didactic lectures, training booklets, and more.
ISSCA’s stem cell certification course offers hands-on, personalized training in harvesting stem cells from a live patient. ISSCA has trained more than 2,000 physicians worldwide. The course is only available to eight physicians per training, so it is important to sign up early to reserve a seat.
The ISSCA regenerative medicine training course was developed for physicians and high-level practitioners to learn techniques in harvesting and reintegrating stem cells.
Stem cell therapies continue to revolutionize the healthcare industry and help improve the quality of life for patients.
To learn more about the ISSCA certification training course and register to participate, visit the Stem Cell Training Course website, email info@stemcellsgroup.com, or call 305-560-5337.
About ISSCA:
The International Society for Stem Cell Application (ISSCA) is a multidisciplinary community of scientists and physicians, all of whom aspire to treat diseases and lessen human suffering through advances in science, technology and the practice of regenerative medicine. ISSCA serves its members through advancements made to the specialty of regenerative medicine.
The ISSCA’s vision is to take a leadership position in promoting excellence and setting standards in the regenerative medicine fields of publication, research, education, training, and certification.
As a medical specialty, regenerative medicine standards and certifications are essential, which is why ISSCA offers certification training in cities all over the world. The goal is to encourage more physicians to practice regenerative medicine and make it available to benefit patients both nationally and globally. Incorporated under the Republic of Korea as a non-profit entity, the ISSCA is focused on promoting excellence and standards in the field of regenerative medicine.
- Published in Press Releases
